Tradestie Institutional Equity Comparison Engine

BGM vs GLPG โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-19 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

GLPG Overall Edge

GLPG Captures Institutional Edge (3โ€“1 Pillars ยท 8โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Galapagos NV (GLPG) driven by superior Valuation, Growth & Margin, Options & Structure while BGM counters with relative strength in Momentum & Technical. Fundamentally, BGM trades at N/M Forward P/E with -23.4% operating margin (+69.8% YoY revenue) versus GLPG at N/M Forward P/E and 88.0% operating margin (+1093.2% YoY). In options structure, BGM sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against GLPG sits in UNCLASSIFIED (2nd %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner GLPG
BGM N/M vs GLPG N/M Fwd P/E
Growth & Margin Winner GLPG
Op Margin -23.4% vs 88.0% ยท YoY +69.8% vs +1093.2%
Momentum & Technical Winner BGM
1Y -17.5% vs +5.6% ยท 52W Pos 74% vs 23%
Options & Structure Winner GLPG
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (2nd %ile IV)
BGM NASDAQ
BGM Group Ltd. Class A Ordinary Shares
Pharmaceutical Preparations
$8.00
-1.6% 1D
Market Cap $108.6M
1M Return -21.57%
1Y Return -17.53%
Forward P/E N/M
Unified AI Score
59.6 / 100 HOLD
Tech 65.0 Fund 55.0 Flow 50.0 Mom 50.0
GLPG NASDAQ
Galapagos NV
Pharmaceutical Preparations
$27.73
-3.75% 1D
Market Cap $1.9B
1M Return -4.02%
1Y Return +5.56%
Forward P/E N/M
Unified AI Score
61.5 / 100 BUY
Tech 45.0 Fund 52.0 Flow 50.0 Mom 64.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: BGM -17.53% GLPG +5.56% Spread: +85.0 pp (GLPG Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
BGM TTM Op. Margin: -23.4% GLPG TTM Op. Margin: 88.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on BGM vs GLPG. Trailing 12-month operating profitability (BGM -23.4% vs GLPG 88.0%) and valuation multiples (BGM N/M vs GLPG N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: BGM (1) vs GLPG (8)
Institutional Metric BGM GLPG Criterion Row Winner
Market Capitalization Scale $108.6M $1.9B Larger Scale GLPG
Trailing P/E Ratio Valuation N/M 5.1x Lower Multiple GLPG
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +69.8% +1093.2% Higher Growth GLPG
Operating Margin (TTM) Profitability -23.4% 88.0% Higher Margin GLPG
Net Profit Margin Profitability -44.2% 28.8% Higher Margin GLPG
Return on Equity (ROE) Capital Efficiency -7.4% 10.4% Higher ROE GLPG
52-Week Range Position Momentum 74% ($0โ€“$11) 23% ($25โ€“$38) Stronger Trend BGM
Beta / 30D Volatility Risk Regime 3.69ฮฒ ยท 80% Vol 0.71ฮฒ ยท 20% Vol Lower Realized Risk GLPG
Unified Institutional Score Composite Signal 59.6 / 100 (HOLD) 61.5 / 100 (BUY) Higher Composite GLPG

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full BGM vs GLPG Buy Guide
BGM UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live BGM Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
GLPG UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 2nd %ile
IV Regime Compressed (<25th %ile)
Live GLPG Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither BGM nor GLPG registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.